Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulatory B cells contribute to allergen-encapsulating nanoparticle immunotherapy efficacy for food allergy.

JCI insight·2026
Same author

Immune Biomarkers of Islet Transplant Rejection Revealed by Synthetic Immunological Niche.

bioRxiv : the preprint server for biology·2026
Same author

Nanoparticle Modulation of Immune and Vascular Microenvironment Dynamics Following Spinal Cord Injury.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Nanoparticle induction of antigen-presenting monocyte-derived dendritic cells relieves immunosuppression and inhibits metastasis.

Cell biomaterials·2026
Same author

Enhanced splicing modulation by NMA-modified antisense oligonucleotides.

Nucleic acids research·2026
Same author

Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma.

Cancer communications (London, England)·2026

Related Experiment Video

Updated: Jun 14, 2025

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

7.2K

Anti-TNF-α antisense-oligonucleotide-conjugated PLG nanoparticles protect transplanted islets.

Elizabeth J Bealer1, Namit Padgaonkar1, Kelly Crumley1

  • 1Department of Biomedical Engineering, University of Michigan, 1119 Carl A. Gerstacker Building, 2200 Bonisteel Boulevard, Ann Arbor, MI 48109, USA.

Molecular Therapy. Methods & Clinical Development
|June 11, 2025
PubMed
Summary

New nanoparticles combat inflammation after islet transplantation for type 1 diabetes. These anti-tumor necrosis factor-alpha nanoparticles protect transplanted islets, improving survival and function in diabetic mice.

Keywords:
SC isletsTNF-αantisense oligonucleotidecell transplantinflammation

More Related Videos

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
12:48

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

65.2K
Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
06:06

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Published on: March 9, 2019

5.5K

Related Experiment Videos

Last Updated: Jun 14, 2025

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

7.2K
PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
12:48

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

65.2K
Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
06:06

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Published on: March 9, 2019

5.5K

Area of Science:

  • Immunology
  • Biotechnology
  • Regenerative Medicine

Background:

  • Inflammation poses a significant challenge to islet transplantation success in type 1 diabetes treatment.
  • Immune cells release inflammatory factors like tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), inducible nitric oxide synthase (iNOS), and IL-6, leading to islet dysfunction and death.
  • Reducing early post-transplant inflammation is crucial for enhancing islet survival and function.

Purpose of the Study:

  • To develop and evaluate anti-TNF-α antisense-oligonucleotide-conjugated polylactide-co-glycolide nanoparticles (PLG-aTNF-α NPs) as an anti-inflammatory therapy.
  • To assess the efficacy of PLG-aTNF-α NPs in protecting stem-cell-derived islets post-transplantation in a type 1 diabetes model.

Main Methods:

  • Development of shelf-stable PLG-aTNF-α NPs.
  • In vitro assessment of TNF-α secretion and expression in inflammatory macrophages.
  • In vitro evaluation of synergistic effects on IL-1β, IL-6, iNOS, and IL-12.
  • In vivo transplantation of stem-cell-derived islets into diabetic mice treated with PLG-aTNF-α NPs or control PLG NPs.
  • Measurement of TNF-α and IL-1β gene expression in treated mice.

Main Results:

  • PLG-aTNF-α NPs effectively reduced TNF-α secretion and expression in inflammatory macrophages.
  • Synergistic anti-inflammatory effects were observed in vitro, with knockdown of IL-1β, IL-6, iNOS, and IL-12.
  • Transplanted islets were protected in diabetic mice treated with PLG-aTNF-α NPs compared to controls.
  • Reduced Tnfα and Il1β expression in treated mice indicated successful attenuation of the inflammatory response.

Conclusions:

  • PLG-aTNF-α NPs demonstrate significant potential as a therapeutic agent to mitigate inflammation in islet transplantation.
  • The developed nanoparticles effectively reduce TNF-α and protect transplanted islets, supporting their clinical application.
  • This approach offers a promising strategy to improve outcomes for type 1 diabetes patients undergoing islet transplantation.